vs
Side-by-side financial comparison of DoubleDown Interactive Co., Ltd. (DDI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
DoubleDown Interactive Co., Ltd. is the larger business by last-quarter revenue ($83.0M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). DoubleDown Interactive Co., Ltd. runs the higher net margin — 30.2% vs -83.0%, a 113.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 13.7%).
Take-Two Interactive Software, Inc. is an American video game holding company based in New York City founded by Ryan Brant in September 1993.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
DDI vs RYTM — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.0M | $57.3M |
| Net Profit | $25.0M | $-47.5M |
| Gross Margin | 70.1% | 91.6% |
| Operating Margin | 42.5% | -82.2% |
| Net Margin | 30.2% | -83.0% |
| Revenue YoY | 13.7% | 36.9% |
| Net Profit YoY | -7.0% | -9.6% |
| EPS (diluted) | $10.11 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | — | $51.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | $83.0M | $33.3M | ||
| Q2 24 | $88.2M | $29.1M | ||
| Q1 24 | $88.1M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | — | $-52.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $25.0M | $-43.6M | ||
| Q2 24 | $33.2M | $-32.3M | ||
| Q1 24 | $30.3M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | 70.1% | 88.5% | ||
| Q2 24 | 69.6% | 89.9% | ||
| Q1 24 | 68.9% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | 42.5% | -132.0% | ||
| Q2 24 | 41.0% | -139.2% | ||
| Q1 24 | 35.2% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | — | -103.1% | ||
| Q2 25 | — | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 30.2% | -131.2% | ||
| Q2 24 | 37.6% | -110.9% | ||
| Q1 24 | 34.4% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | $10.11 | $-0.73 | ||
| Q2 24 | $13.39 | $-0.55 | ||
| Q1 24 | $12.23 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $372.7M | $388.9M |
| Total DebtLower is stronger | $37.9M | — |
| Stockholders' EquityBook value | $815.5M | $139.1M |
| Total Assets | $879.8M | $480.2M |
| Debt / EquityLower = less leverage | 0.05× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | $372.7M | $298.4M | ||
| Q2 24 | $339.2M | $319.1M | ||
| Q1 24 | $309.5M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $37.9M | — | ||
| Q2 24 | $36.0M | — | ||
| Q1 24 | $37.1M | — |
| Q4 25 | — | $139.1M | ||
| Q3 25 | — | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $815.5M | $11.2M | ||
| Q2 24 | $786.2M | $39.3M | ||
| Q1 24 | $755.2M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | — | $506.9M | ||
| Q2 25 | — | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | — | $392.3M | ||
| Q3 24 | $879.8M | $363.6M | ||
| Q2 24 | $852.6M | $381.8M | ||
| Q1 24 | $831.0M | $258.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.05× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $-25.4M |
| Free Cash FlowOCF − Capex | $31.6M | — |
| FCF MarginFCF / Revenue | 38.0% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $129.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | — | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $31.8M | $-25.2M | ||
| Q2 24 | $34.4M | $-29.1M | ||
| Q1 24 | $34.9M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $31.6M | — | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $34.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 38.0% | — | ||
| Q2 24 | 39.0% | — | ||
| Q1 24 | 39.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.04× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
